BioAro

Menu Close

About Us

Personalized Healthcare

BioAro is committed to enabling healthcare systems to become personalized. By offering genomics, microbiome, and consultation services we are helping our clients take the first step into DNA informed treatment and proactive care.

Individual Autonomy

BioAro is committed to breaking the cycle of private corporations selling data. Instead, we are building a Blockchain system for healthcare that will keep the ownership and autonomy of the individual intact.

Software Innovations (drug discovery, panomics, blockchain)

BioAro is committed to being at the forefront of bioinformatics technology for –omics fields. By building ‘PanOmics’ we will be able to analyse the relationships between all of a client’s molecular data, whether that be your DNA, proteins, metabolites, etc. alongside their medical scans and imaging like x-rays. This platform will be licensable and available to institutions to fuel drug discovery, medical diagnostics, and research.

Core Values

Leadership

Leading by example to create the highest standards of excellence in our field.

Trust & Transparency

Adhering to the highest standards of professionalism, ethics and personal responsibility.

Innovation

People as partners in new discoveries that will advance our understanding of medicine, health, and the building blocks of life.

Care

Striving to create lasting change for our customers and communities.

Education

Connecting individuals and health care providers to the tools they need. We'll never leave you to decipher what your results might means.  

Proudly Canadian

We keep your information securely stored within Canada.

What makes BioAro different?

BioAro applies a unique multidisciplinary approach to genomic testing that enhances our already exceptional
customer service. The team at BioAro is composed of passionate experts working to revolutionize and innovate
within the biotech and medical fields. Current Canadian and world genetic testing businesses have put a greater
emphasis on pre-established NGS technology and analysis tools that provide limited reports on narrowly selected
genes. BioAro fills this gap by expanding on existing research and developing AI tools that will pave the way toward
personalized medicine, not only for cancer patients, but also the generally healthy population. The longevity of
BioAro lies in its desire for continuous growth, to facilitate the democratization of genomic data using blockchain
technology.

BioAro is the first of its kind in Canada and we intend to expand our innovative services across the world.

Mission

Building a community of individuals, health care providers and researchers to transform the health care landscape and drive transformative genetic discovery. In today’s health care system, health services focus less on the individual and more on population health recommendations, implying that one size fits all, and in healthcare it doesn’t. Through our multi-omic (nutrigenomics, proteomics, pharmacogenomics, transcriptomics, and metabolomics) we’re enabling customized, more precise health outcomes, focusing on the person, not the population.

Vision

Vision BioAro aims to further the implementation of genomic research into the Canadian health care system, advance progress toward personalized medicine, and place genomic ownership in the hands of the individual. We see a future where genetic analysis services are accessible to everyone. Genomics improves the wellness and healthcare of everyday life, today and for generations to come. Our aims will be accomplished by leveraging innovative technology such as blockchain for privacy and personalizing healthcare by understanding genome sequencing, and its impact lifestyle and wellness.

Our Mission

“DNA can personalize and improve your healthcare, BioAro is working to make this the standard.”
Personal health: Healthcare systems across the world use traditional methods of population healthcare, which uses treatment methods catered to the largest populations. Our mission is to bring about a shift in these methodologies from a population centred approach to a personalized one.
Personal accessibility: Every person is unique. That uniqueness is recorded in our DNA and other molecules, which changes our risk for the development of certain health conditions and the effectiveness of treatments. With genomics technology becoming increasingly more accessible in the 21st century, so has our ability to understand how our DNA can inform our healthcare. BioAro aims to provide everyone the chance at preventative care and personalized medical treatment, which can reduce medical costs, time, and suffering.
Personal autonomy: By using artificial intelligence and Blockchain technology the individual will retain DNA information ownership, autonomy and privacy. Sharing genetic profile data is the sole choice of the individual, however they may opt to have their information used by their healthcare team, researchers, or to pass on to their kids to improve the healthcare available to their familial beneficiaries.

Our Vision

“Future healthcare will be driven not only by the symptoms we can see, but also all of the unique life giving molecules we cannot see with the naked eye.”
Integration: Technological advancements have grown exponentially over the past century, sometimes faster than we can adapt or integrate new innovations. We foresee the integration of DNA and genetic profiles in future medical records. This means a shift from healthcare workers asking:
“Based on the symptoms we see, what is the typical approach to try and treat this health condition?” (population centred)
to
“Based on this individual’s genetic profile, what is the right treatment for this person with this health condition?” (personalized)
The difference in available information to the healthcare team can mean the difference between months of trialling different treatments to being prescribed the right medication and seeing the recovery process begin much more rapidly.
Beyond human health: Even further in the future, the use of genomics technology to treat and care for our pets, commercial animals, and to protect endangered species is likely to become commonplace. This also applies to our agricultural practices and food safety. We have already seen genomics used in these ways and as our capacity expands, BioAro looks forward to being a leading organization in promoting genomics use in every industry to improve community wellness.

Our Guiding Values

“The smallest things that make life, mean the most to living life to its fullest.”

Humanity

We look at each genome sequence as a chapter in a book containing all of the amazing stories that make you and your health unique.

Science

All of our services lead with critical evidence-based research. You can be assured that our tests are updated with the newest findings in the field.

Speed

When it comes to your health, time is always a critical element. This is why we have designed our operations to be as rapid as they can be without compromising the quality of reporting.

Education

Genetic information should not be locked behind knowledge barriers. We have registered specialists and connect individuals & healthcare providers to the tools they need to understand test results.

Empower

By providing our clients detailed on their genetic profile and counselling services, we are empowering them to become leaders in their own healthcare.

Revolution

We believe in the promise of a brighter future. This involves replacing traditional practices with modern innovations.

Growth

We are committed to continuously grow and expand not only where our services are available, but also to the range of our services.

Trust

We value the privacy of our customers’ information and hold ourselves to the highest standards of personal responsibility.

What makes BioAro different?

BioAro applies a unique multidisciplinary approach to genomic testing that enhances our already exceptional customer service. The team at BioAro is composed of passionate experts working to revolutionize and innovate within the biotech and medical fields. Current Canadian and world genetic testing businesses have put a greater emphasis on pre-established technology and analysis tools that provide limited reports on narrowly selected genes. BioAro fills this gap by expanding on existing research and developing AI tools that will pave the way toward personalized medicine, not only for cancer patients, but also the generally healthy population. The longevity of BioAro lies in its desire for continuous growth and to facilitate the rise of individual autonomy over genomic data using Blockchain technology.

Democratize access to genomic data for the revolutionization of the genomic field for human health, agriculture, and the environment. Through this, novel gene and drug discoveries can be made.

    • • Enable access and control of health data to clients and provide precision medicine assessments and wellness strategies through a multi-omics approach.
  •  
      • Adapt  precision  medicine  total  assessment strategies  to  agriculture, horticulture,  and  environmental  management  to improve  efficiencies  and minimize the environmental impact of human activity on natural systems.
  • • Develop algorithms to integrate genomic analysis with alternative sequencing and  other health metrics to develop a personalized health assessment,  and  recommend treatment/lifestyle strategies for best outcome.
    • Develop genomic testing for human health, associating clinical genetic  vulnerabilities with clinical outcomes.
    • Offer genomic testing in the field of health and agriculture for North America and around the world.

Vision

BioAro aims to further the implementation of genomic research into the Canadian health care system, advance progress toward
personalized medicine, and create DNA democratization to have genomic ownership in the hands of the individual. We see a
future where genetic analysis services are accessible to everyone, genomics improves the wellness and healthcare of everyday
life, while also protecting our agricultural and ecological systems. Our aims will be accomplished by leveraging innovative
technology such as blockchain for privacy and autonomy and artificial intelligence for pharmacogenomics and clinical trial
advancements.

Vision

to further the implementation of genomic research into the Canadian health care system.

to further the development and accessibility of Precision medicine/ personal medicine – integrative health care.

DNA democratization – as the legality around genome ownership evolves, we want to be at the forefront, advocating for personal ownership of genetic information.

Pipeline into clinical trials.

increasing the accessibility of genetic analysis services.

BioAro is looking to revolutionize the future of healthcare by using artificial intelligence and blockchain technology to create a path toward personalized medicine. 

Adapt  precision  medicine  total  assessment strategies  to  agriculture, horticulture,  and  environmental  management  to improve  efficiencies  and minimize the environmental impact of human activity on natural systems.

Develop algorithms to integrate genomic analysis with alternative sequencing and  other health metrics to develop a personalized health assessment,  and  recommend treatment/lifestyle strategies for best outcome.

Develop genomic testing for human health, associating clinical genetic  vulnerabilities with clinical outcomes.

Offer genomic testing in the field of health and agriculture for North America and around the world.

Leadership

By providing mentorship, guidance and a clear path to success, healthcare solutions and improved quality of life is achieved.

Integrity

We adhere to the highest standards of professionalism, ethics and personal responsibility, worthy of the trust our people have in BioAro to support their health.

Excellence

At BioAro we are constantly in pursuit of excellence every day and in everything we do to ensure execution of the highest standards in the business.

Care

We care about the world we live in by promoting healthy living choices for a healthier community.

Innovation

We energize our organization by enhancing the lives of those we serve, through the innovation of unique, educated and remarkable abilities of our team.

Precision and accuracy

Our accuracy consists of trueness proximity of measurement results to the true value and precision; repeatability or reproducibility that transforms to confidence in our products.

What makes BioAro different?

At BioAro, we not only pride ourselves with the exceptional service offered to customers, but also  with our unique multidisciplinary approach to genetic and genomic testing. The passion of the  team at BioAro in contributing to and even revolutionizing the field of innovation within biotech, is  another factor that distinguishes BioAro.

The current Canadian genetic and genomic testing market places a greater emphasis on using  pre-established NGS technology and analysis tools to provide often limited reports that focus on  narrowly select genes. BioAro fills a gap in this market by stepping outside of the ordinary and  developing AI based tools such as an NGS based software that allow for personalized medicine  across the disciplines; from pharmacogenomics to oncology.

The longevity of this corporation lies in its great desire in continuous growth, to facilitate the  democratization of access to genomic data through incorporation of blockchain technologies and  cryptocurrencies. BioAro’s platform will be the first Canadian-based of its kind.

Our Team

“The first of its kind in Canada.”
The BioAro team brings a wealth of knowledge and experience to all of its service offerings. We consist of PhDs, MDs, and field experts in genomics, microbiomes, bioinformatics, artificial intelligence, and Blockchain technologies.

Dr. Anmol Kapoor,MD, FRCPC ©

Internal Medicine Specialist and Cardiologist CEO & Founder of BioAro Inc.

Patrick Kirkwood

Vice President Business Development and Investor Relations

Margaret Renaud Young, PhD

Head of Genomic Facility

Raja B. Singh MBBS,MS, PhD

Vice President of Research and Innovation BioAro Inc.

Afnan Alkhafaji, MSc

Genomic Research Scientist & Variant Analyst

Teenus Jayaprakash, PhD

Microbiome and Genomics Scientist

Vivek Krishna Venu, PhD

Pharmacogenomic Research Scientist

Igor Kovalchuk

Chief Scientific Officer

Christian Emond, BSC

Marketing and Genomics Specialist

Raman Koul PhD

Manager of Genomic Client Services and CardiAl Laboratories

Sadia Batool

M.D. Family Physician, Genomic operations